Communication Bridge™-2 (CB2): an NIH Stage 2 randomized control trial of a speech-language intervention for communication impairments in individuals with mild to moderate primary progressive aphasia
2022 · Trials · 24 citations
https://doi.org/10.1186/s13063-022-06162-7